Superdisintegrants Market Report 2026

Superdisintegrants Market Overview

• Superdisintegrants market size has reached to $1.16 billion in 2025 • Expected to grow to $1.56 billion in 2030 at a compound annual growth rate (CAGR) of 6% • Growth Driver: Rising Generic Drug Production Fuels The Market Growth • Market Trend: Advancing Tablet Manufacturing With Enhanced Powder Flow And Disintegration Technology • North America was the largest region in 2025.

What Is Covered Under Superdisintegrants Market?

Superdisintegrants are pharmaceutical excipients specifically designed to enhance the disintegration of tablets or capsules, facilitating faster release and absorption of the active pharmaceutical ingredient (API) in the body. They are crucial for improving the bioavailability of drugs and ensuring their efficacy, especially in orally administered medications. The main types of superdisintegrants are natural superdisintegrants, synthetic superdisintegrants, and other superdisintegrants. Natural superdisintegrants are plant-based or naturally derived substances that enhance the breakdown of tablets in the gastrointestinal tract, improving drug dissolution and absorption. Superdisintegrants are utilized in various formulations, including tablets and capsules, and play a crucial role across multiple therapeutic areas such as gastrointestinal diseases, neurological diseases, oncology, infectious diseases, cardiovascular diseases, and hematological diseases.

What Is The Superdisintegrants Market Growth Forecast?

The superdisintegrants market size is expected to see strong growth in the next few years. It will grow to $1.56 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to growing focus on patient-centric drug delivery, rising demand for pediatric and geriatric formulations, expansion of novel oral drug delivery systems, increasing R&D investment in excipient optimization, adoption of multifunctional excipient solutions. Major trends in the forecast period include increasing adoption of rapid disintegrating tablet formulations, rising demand for high-performance synthetic superdisintegrants, growing use of natural and plant-based disintegrants, expansion of orally disintegrating drug products, enhanced focus on bioavailability enhancement.

What Is The Driver Of The Superdisintegrants Market?

Increasing generic drug production is expected to propel the growth of the superdisintegrants market going forward. A generic drug is a medication that has the same active ingredients, dosage, strength, route of administration, quality, and performance as a brand-name drug but is typically sold at a lower cost. Increasing generic drug production is driven by the rising demand for affordable medications, patent expirations of branded drugs, and government initiatives to reduce healthcare costs. Superdisintegrants in generic drugs enhance tablet disintegration and dissolution, ensuring faster drug release, improved bioavailability, and better patient compliance. For instance, in 2025, according to a report published by the Association for Accessible Medicines, a US-based government department, In 2024, Americans filled 3.9 billion prescriptions for generic drugs compared to just 435 million for brand-name medications, yet spending on generics totaled only $98 billion. Therefore, the increasing generic drug production is driving the growth of the superdisintegrants industry.

Key Players In The Global Superdisintegrants Market

Major companies operating in the superdisintegrants market are BASF SE, Merck KGaA, DuPont de Nemours Inc., IFF Pharma Solutions, Ingredion Incorporated, Roquette Freres SA., FMC Corporation, Azelis Group, Ashland Inc., Piramal Healthcare, Colorcon Inc. Ltd., Boai NKY Pharmaceuticals Ltd., JRS Pharma, Faran Shimi Pharmaceutical, DFE Pharma India Private Limited., Sigachi Industries Limited, Corel Pharma Chem, Maple Biotech Pvt. Ltd., Shanghai Chineway Pharmaceutical Technology Co. Ltd., JH Nanhang Life Sciences Co. Ltd.

Global Superdisintegrants Market Trends and Insights

Major companies operating in the superdisintegrants market are focusing on novel offerings, such as multifunctional disintegrants, to enhance drug formulation efficiency, improve tablet disintegration speed, and optimize patient compliance in pharmaceutical applications. A multifunctional disintegrant is an advanced excipient that combines disintegration, binding, and flow-enhancing properties to improve tablet formulation efficiency and drug release. For instance, in June 2023, Ashland Inc., a US-based chemicals company, launched Polyplasdone Plus, a co-processed multifunctional direct compression superdisintegrant designed to enhance tablet disintegration, powder flow, and lubrication during pharmaceutical manufacturing. This innovation simplifies production by eliminating two manufacturing steps, improving tablet hardness, and supporting high-speed and continuous manufacturing processes.

What Are Latest Mergers And Acquisitions In The Superdisintegrants Market?

In April 2023, Ingredion Inc., a US-based food company, acquired Amishi Drugs & Chemicals Private Limited for an undisclosed amount. With this acquisition, Ingredion aims to expand its specialty pharmaceutical product portfolio, enhance its expertise in functional excipients, strengthen its presence in the fast-growing Indian pharmaceutical market, and support global exports with high-quality, pharma-grade ingredients. Amishi Drugs & Chemicals Private Limited is an India-based manufacturer of superdisintegrants for enhanced tablet disintegration and drug formulation.

What Defines the Superdisintegrants Market?

The superdisintegrants market consists of sales of co-processed superdisintegrants, polymer-based superdisintegrants, and cross-linked superdisintegrants. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Superdisintegrants Market Report 2026?

The superdisintegrants market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the superdisintegrants industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.